Firebrick Pharma’s Nasodine Expands With Guardian Health & Beauty In Singapore
Nasodine will launch in Singapore in January 2025, available exclusively at Guardian pharmacies for 12 months.
Nasodine, a product by Firebrick Pharma, will soon be available at all 121 Guardian Health & Beauty retail pharmacies across Singapore. Guardian, one of the country's largest pharmacy chains, has secured an exclusive distribution agreement for Nasodine for 12 months. The launch of Nasodine is set for January 2025. The locations also include Guardian’s six prime outlets at Changi Airport.
This partnership marks a key milestone for Firebrick, developing Nasodine's growth from online sales to being actively promoted. The collaboration will aid in recommending physical retail locations. This initiative complements the ongoing marketing efforts targeting doctors and hospitals, which are being carried out in partnership with Innorini Life Sciences. With these combined strategies, significant sales growth is expected to lift in 2025.
My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.
Mehr aus Pharma News
Alle Beiträge →
Medicus Pharma reicht Phase‑2b/3‑Protokoll für Teverelix bei der FDA ein
Fresenius Kabi erhält FDA-Warnschreiben nach Fehlern bei der Untersuchung aseptischer Verarbeitung in der Anlage Melrose Park
Discussion